Grace Nambatya Kyeyune

A natural formulation developed by Nambatya and her team at NCRI. Since January 2021 it is undergoing human clinical trials at Mulago National Referral Hospital.

She also sits on the board of the National Drug Authority, since 2008. She is the chair of the Public Private Partnership for Health (PPPH) Working Group. She is also a member of the Top Management Team at the Uganda Ministry of Health, answerable directly to the Permanent Secretary.

Starting circa 2000, Nambatya has been studying and promoting indigenous herbal medication, working with Ugandan communities, herbalists and western medical practitioners. She is credited with being the driving force "behind the Indigenous and Complementary Medicine Bill of 2015".

Grace Nambatya Kyeyune (née Grace Nambatya) (born April 1962), is a Ugandan medicinal chemist, researcher and academic, who serves as the Director of Research at the National Chemotherapeutic Research Institute (NCRI), based in Kampala, Uganda's capital city. According to its website, NCRI is a state-owned "research and development institute in natural products and traditional and complementary health systems". As of July 2021, Nambatya is credited with developing five compounds, currently in clinical and public use, which are extracted from Ugandan plants and herbs.

Nambatya was born in April 1962 to Mary Perepetwa Sonko and Charles Sonko of Ssaza, Masaka District, in the Buganda Region of Uganda. She attended primary school in the greater Masaka area. She then transferred to Trinity College Nabbingo, in present-day Wakiso District, where she completed both her O-Level and A-Level studies.